Howard Lee - May 20, 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
May 20, 2021
Transactions value $
-$33,054
Form type
4
Date filed
5/24/2021, 04:45 PM
Next filing
Jun 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $164K +10K +7.52% $16.43 143K May 20, 2021 Direct
transaction AMPH Common Stock Sale -$197K -10K -7% $19.74 133K May 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -10K -38.72% $0.00 15.8K May 20, 2021 Common Stock 10K $16.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.66 to $19.945 shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.